Ablation for oligometastatic colorectal carcinoma in extrahepatic, extrapulmonary sites

References

• Stewart CL, Warner S, Ito K, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330–379.
   PubMed Web of Science ®Google Scholar
• Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25(29):4575–4580.
   PubMed Web of Science ®Google Scholar
• Gonzalez M, Poncet A, Combescure C, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572–579.
   PubMed Web of Science ®Google Scholar
• Lee-Ying R, Bernard B, Gresham G, et al. A comparison of survival by site of metastatic resection in metastatic colorectal cancer. Clin Colorectal Cancer. 2017;16(2):e23–e8.
   PubMed Web of Science ®Google Scholar
• Meijerink MR, Puijk RS, van Tilborg A, et al. Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2018;41(8):1189–1204.
   PubMed Web of Science ®Google Scholar
• Tanis E, Nordlinger B, Mauer M, et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer. 2014;50(5):912–919.
   PubMed Web of Science ®Google Scholar
• Ruers T, Van Coevorden F, Punt CJ, et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015. DOI:10.1093/jnci/djx015.
   PubMedGoogle Scholar
• Zhong J, Palkhi E, Ng H, et al. Long-term outcomes in percutaneous radiofrequency ablation for histologically proven colorectal lung metastasis. Cardiovasc Intervent Radiol. 2020;43(12):1900–1907.
   PubMed Web of Science ®Google Scholar
• Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013. Eur Radiol. 2015;25(12):3438–3454.
   PubMed Web of Science ®Google Scholar
• Phelip JM, Tougeron D, Leonard D, et al. Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis. 2019;51(10):1357–1363.
   PubMedGoogle Scholar
• Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422.
   PubMed Web of Science ®Google Scholar
• Cashin PH, Mahteme H, Spang N, et al. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: a randomised trial. Eur J Cancer. 2016;53:155–162.
   PubMed Web of Science ®Google Scholar
• Quenet F, Elias D, Roca L, UNICANCER-GI Group and BIG Renape Group, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256–266.
   PubMed Web of Science ®Google Scholar
• Wong JS, Tan GH, Teo MC. Management of para-aortic lymph node metastasis in colorectal patients: A systemic review. Surg Oncol. 2016;25(4):411–418.
   PubMed Web of Science ®Google Scholar
• Callstrom MR, Dupuy DE, Solomon SB, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer. 2013;119(5):1033–1041.
   PubMed Web of Science ®Google Scholar
• Gardner CS, Ensor JE, Ahrar K, et al. Cryoablation of bone metastases from renal cell carcinoma for local tumor control. J Bone Joint Surg Am. 2017;99(22):1916–1926.
   PubMed Web of Science ®Google Scholar
• Vaswani D, Wallace AN, Eiswirth PS, et al. Radiographic local tumor control and pain palliation of sarcoma metastases within the musculoskeletal system with percutaneous thermal ablation. Cardiovasc Intervent Radiol. 2018;41(8):1223–1232.
   PubMed Web of Science ®Google Scholar
• Littrup PJ, Bang HJ, Currier BP, et al. Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol. 2013;24(12):1817–1825.
   PubMed Web of Science ®Google Scholar
• McMenomy BP, Kurup AN, Johnson GB, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013;24(2):207–213.
   PubMed Web of Science ®Google Scholar
• Filippiadis D, Charalampopoulos G, Tsochatzis A, et al. Feasibility and safety of percutaneous computed tomography guided radiofrequency ablation of lymph nodes in oligometastatic patients: a single center's experience. Br J Radiol. 2021;94(1121):20200445.
   PubMed Web of Science ®Google Scholar
• Maiettini D, De Angelis V, Graziosi L, et al. Sacrum colon-rectal cancer metastasis: microwave ablation for palliative pain treatment. Recenti Prog Med. 2016;107(12):673–676.
   PubMedGoogle Scholar
• Marangio A, Prati U, Luinetti O, et al. Radiofrequency ablation of colorectal splenic metastasis. AJR Am J Roentgenol. 2002;178(6):1481–1482.
   PubMed Web of Science ®Google Scholar
• Wessel BE, Coldwell D. Colon cancer metastasis to the sternum: palliative treatment with radiofrequency ablation and cement injection. Radiol Case Rep. 2016;11(4):357–360.
   PubMedGoogle Scholar
• Cazzato, RL, De, Marini P, Leonard-Lorant, I, Dalili, D, Koch, G, Autrusseau, PA, et al. Percutaneous thermal ablation of sacral metastases: Assessment of pain relief and local tumor control. Diagn Interv Imaging. 2021;102(6):355–361.
   PubMed Web of Science ®Google Scholar
• Deschamps F, Farouil G, Ternes N, et al. Thermal ablation techniques: a curative treatment of bone metastases in selected patients? Eur Radiol. 2014;24(8):1971–1980.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zheng L, Liang P, et al. Evaluating the efficacy and safety of ultrasound-guided percutaneous microwave ablation for the treatment of adrenal metastasis. J Cancer Res Ther. 2020;16(5):1088–1092.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Yamakado K, Nakatsuka A, et al. Unresectable adrenal metastases: clinical outcomes of radiofrequency ablation. Radiology. 2015;277(2):584–593.
   PubMed Web of Science ®Google Scholar
• Levy J, Hopkins T, Morris J, et al. Radiofrequency ablation for the palliative treatment of bone metastases: outcomes from the multicenter Osteocool tumor ablation post-market study (OPuS One Study) in 100 patients. J Vasc Interv Radiol. 2020;31(11):1745–1752.
   PubMed Web of Science ®Google Scholar
• Wallace AN, McWilliams SR, Connolly SE, et al. Percutaneous image-guided cryoablation of musculoskeletal metastases: pain palliation and local tumor control. J Vasc Interv Radiol. 2016;27(12):1788–1796.
   PubMed Web of Science ®Google Scholar
• Welch BT, Callstrom MR, Carpenter PC, et al. A single-institution experience in image-guided thermal ablation of adrenal gland metastases. J Vasc Interv Radiol. 2014;25(4):593–598.
   PubMed Web of Science ®Google Scholar
• Parvinian A. A single-institution experience in percutaneous image-guided cryoablation of lymph node metastases. AJR. 2021;217(1):152–156.
   PubMed Web of Science ®Google Scholar
• Butros SR, DelCarmen MG, Uppot RN, et al. Image-guided percutaneous thermal ablation of metastatic pelvic tumor from gynecologic malignancies. Obstet Gynecol. 2014;123(3):500–505.
   PubMed Web of Science ®Google Scholar
• Erie AJ, Morris JM, Welch BT, Kurup AN, et al. Retrospective review of percutaneous image-guided ablation of oligometastatic prostate cancer: a single-institution experience. J Vasc Interv Radiol. 2017;28(7):987–992.
   PubMed Web of Science ®Google Scholar
• Barral M, Auperin A, Hakime A, et al. Percutaneous thermal ablation of breast cancer metastases in oligometastatic patients. Cardiovasc Intervent Radiol. 2016;39(6):885–893.
   PubMed Web of Science ®Google Scholar
• Bang HJ, Littrup PJ, Goodrich DJ, et al. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol. 2012;23(6):770–777.
   PubMed Web of Science ®Google Scholar
• Welch BT, Callstrom MR, Morris JM, et al. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol. 2014;192(2):357–363.
   PubMed Web of Science ®Google Scholar
• Hirbe AC, Jennings J, Saad N, et al. A phase II study of tumor ablation in patients with metastatic sarcoma stable on chemotherapy. Oncologist. 2018;23(7):760–e76.
   PubMed Web of Science ®Google Scholar
• White ML, Atwell TD, Kurup AN, et al. Recurrence and survival outcomes after percutaneous thermal ablation of oligometastatic melanoma. Mayo Clin Proc. 2016;91(3):288–296.
   PubMed Web of Science ®Google Scholar
• Cazzato RL, Garnon J, Caudrelier J, et al. Percutaneous radiofrequency ablation of painful spinal metastasis: a systematic literature assessment of analgesia and safety. Int J Hyperthermia. 2018;34(8):1272–1281.
   PubMed Web of Science ®Google Scholar
• Molla M, Fernandez-Plana J, Albiol S, et al. Limited liver or lung colorectal cancer metastases. Systemic treatment, surgery, ablation or SBRT. JCM. 2021;10(10):2131.
   Web of Science ®Google Scholar
• Petre EN, Jia X, Thornton RH, et al. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clin Colorectal Cancer. 2013;12(1):37–44.
   PubMed Web of Science ®Google Scholar
• Sag AA, Selcukbiricik F, Mandel NM. Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. World J Gastroenterol. 2016;22(11):3127–3149.
   PubMed Web of Science ®Google Scholar
• Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol. 2018;41(10):1530–1544.
   PubMed Web of Science ®Google Scholar
• Fonck M, Perez JT, Catena V, et al. Pulmonary thermal ablation enables long chemotherapy-free survival in metastatic colorectal cancer patients. Cardiovasc Intervent Radiol. 2018;41(11):1727–1734.
   PubMed Web of Science ®Google Scholar
• Hosein PJ, Echenique A, Loaiza-Bonilla A, et al. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system. J Vasc Interv Radiol. 2014;25(8):1233–1239 e2.
   PubMed Web of Science ®Google Scholar
• Silk MT, Wimmer T, Lee KS, et al. Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol. 2014;25(1):112–118.
   PubMed Web of Science ®Google Scholar
• Pan S, Baal JD, Chen WC, et al. Image-guided percutaneous ablation of adrenal metastases: a meta-analysis of efficacy and safety. J Vasc Interv Radiol. 2021;32(4):527–535 e1.
   PubMed Web of Science ®Google Scholar
• Kurup AN, Schmit GD, Morris JM, et al. Avoiding complications in bone and soft tissue ablation. Cardiovasc Intervent Radiol. 2017;40(2):166–176.
   PubMed Web of Science ®Google Scholar
• Kitchin D, Lubner M, Ziemlewicz T, et al. Microwave ablation of malignant hepatic tumours: intraperitoneal fluid instillation prevents collateral damage and allows more aggressive case selection. Int J Hyperthermia. 2014;30(5):299–305.
   PubMed Web of Science ®Google Scholar
• Kurup AN, Morris JM, Schmit GD, et al. Neuroanatomic considerations in percutaneous tumor ablation. Radiographics. 2013;33(4):1195–1215.
   PubMed Web of Science ®Google Scholar
• Kurup AN, Morris JM, Boon AJ, et al. Motor evoked potential monitoring during cryoablation of musculoskeletal tumors. J Vasc Interv Radiol. 2014;25(11):1657–1664.
   PubMed Web of Science ®Google Scholar
• Favazza CP, Gorny KR, King DM, et al. An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: a phantom study. Cryobiology. 2014;69(1):128–133.
   PubMed Web of Science ®Google Scholar
• Marion JT, Schmitz JJ, Schmit GD, et al. Safety and efficacy of retrograde pyeloperfusion for ureteral protection during renal tumor cryoablation. J Vasc Interv Radiol. 2020;31(8):1249–1255.
   PubMed Web of Science ®Google Scholar
• Otto G, Duber C, Hoppe-Lotichius M, et al. Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery. Ann Surg. 2010;251(5):796–803.
   PubMed Web of Science ®Google Scholar
• Vigano L, Pedicini V, Comito T, et al. Aggressive and multidisciplinary local approach to iterative recurrences of colorectal liver metastases. World J Surg. 2018;42(8):2651–2659.
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR. The 46th David A. Karnofsky memorial award lecture: oligometastasis-from conception to treatment. J Clin Oncol. 2018;36(32):3240–3250.
   PubMed Web of Science ®Google Scholar
• Pitroda SP, Khodarev NN, Huang L, et al. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018;9(1):1793.
   PubMed Web of Science ®Google Scholar
• Jin Z, Sanhueza CT, Johnson B, et al. Outcome of mismatch repair-deficient metastatic colorectal cancer: the Mayo Clinic experience. The Oncol. 2018;23(9):1083–1091.
   PubMed Web of Science ®Google Scholar